These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28809804)

  • 1. Type 1 Diabetes and Non-Alcoholic Fatty Liver Disease: When Should We Be Concerned? A Nationwide Study in Brazil.
    Barros BSV; Santos DC; Pizarro MH; del Melo LGN; Gomes MB
    Nutrients; 2017 Aug; 9(8):. PubMed ID: 28809804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prevalence of Nonalcoholic Fatty Liver Disease and Its Risk Factors in Children and Young Adults with Type 1 Diabetes Mellitus.
    Sae-Wong J; Chaopathomkul B; Phewplung T; Chaijitraruch N; Sahakitrungruang T
    J Pediatr; 2021 Mar; 230():32-37.e1. PubMed ID: 33250172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes.
    Li TT; Wang AP; Lu JX; Chen MY; Zhao CC; Tang ZH; Li LX; Jia WP
    Diabetes Metab; 2018 Nov; 44(5):437-443. PubMed ID: 29631765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis.
    Kummer S; Klee D; Kircheis G; Friedt M; Schaper J; Häussinger D; Mayatepek E; Meissner T
    Eur J Pediatr; 2017 Apr; 176(4):529-536. PubMed ID: 28213828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.
    Mor A; Svensson E; Rungby J; Ulrichsen SP; Berencsi K; Nielsen JS; Stidsen JV; Friborg S; Brandslund I; Christiansen JS; Beck-Nielsen H; Sørensen HT; Thomsen RW
    Diabetes Metab Res Rev; 2014 Nov; 30(8):707-15. PubMed ID: 24639417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes.
    Cusi K; Sanyal AJ; Zhang S; Hartman ML; Bue-Valleskey JM; Hoogwerf BJ; Haupt A
    Diabetes Obes Metab; 2017 Nov; 19(11):1630-1634. PubMed ID: 28417532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes.
    Mantovani A; Rigolon R; Mingolla L; Pichiri I; Cavalieri V; Salvotelli L; Stoico V; Zoppini G; Bonora E; Targher G
    J Diabetes Complications; 2017 Jun; 31(6):1021-1026. PubMed ID: 28254449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010-2015.
    Kang Y; Park S; Kim S; Koh H
    BMC Pediatr; 2018 Jul; 18(1):215. PubMed ID: 29976192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
    Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
    Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.
    Leite NC; Salles GF; Araujo AL; Villela-Nogueira CA; Cardoso CR
    Liver Int; 2009 Jan; 29(1):113-9. PubMed ID: 18384521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology.
    Memaj P; Jornayvaz FR
    Front Endocrinol (Lausanne); 2022; 13():1031633. PubMed ID: 36531463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort.
    Zelber-Sagi S; Ben-Assuli O; Rabinowich L; Goldstein A; Magid A; Shalev V; Shibolet O; Chodick G
    Liver Int; 2015 Nov; 35(11):2408-15. PubMed ID: 25845417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors associated with non-alcoholic fatty liver disease: a case-control study].
    Caballería L; Arteaga I; Pera G; Rodríguez L; Alumà A; Auladell MA; Torán P
    Med Clin (Barc); 2013 Sep; 141(6):233-9. PubMed ID: 23601740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study.
    Sogabe M; Okahisa T; Nakasono M; Fukuno H; Miyamoto Y; Okada Y; Okazaki J; Miyoshi J; Tomonari T; Taniguchi T; Goji T; Kitamura S; Miyamoto H; Muguruma N; Takayama T
    PLoS One; 2017; 12(6):e0177925. PubMed ID: 28574988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
    Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
    Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.